Medicover AB (publ)

Factors to consider:

• Company pays dividends (annually): last record date 2025-05-02, amount 0.18$ (Y0.66%)
• Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

• 2024-12-31 to 2025-12-31 estimated range: [17.09$, 28.63$]
• 2025-12-31 to 2026-12-31 estimated range: [18.54$, 30.76$]

Financial Metrics affecting the MCVEF estimates:

• Positive: with PPE of 129.1 at the end of fiscal year the price was very low
• Positive: -3.60 < Operating profit margin, % of 3.36
• Positive: 6.82 < Operating cash flow per share per price, % of 12.07
• Positive: 18.93 < Shareholder equity ratio, % of 21.74 <= 41.86
• Positive: Inventory ratio change, % of -0.09 <= 0
• Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of 0.77
• Positive: Interest expense per share per price, % of 2.79 <= 3.41
• Positive: -8.75 < Industry operating profit margin (median), % of -3.16
• Positive: -14.38 < Investing cash flow per share per price, % of -6.21